TY - JOUR
T1 - Rare X chromosome abnormalities in systemic lupus erythematosus and Sjögren's syndrome
AU - Sharma, Rohan
AU - Harris, Valerie M
AU - Cavett, Joshua
AU - Kurien, Biji T
AU - Liu, Ke
AU - Koelsch, Kristi A
AU - Fayaaz, Anum
AU - Chaudhari, Kaustubh S
AU - Radfar, Lida
AU - Lewis, David
AU - Stone, Donald U
AU - Kaufman, C Erick
AU - Li, Shibo
AU - Segal, Barbara
AU - Wallace, Daniel J
AU - Weisman, Michael H
AU - Venuturupalli, Swamy
AU - Kelly, Jennifer A
AU - Pons-Estel, Bernardo
AU - Jonsson, Roland
AU - Lu, Xianglan
AU - Gottenberg, Jacques-Eric
AU - Anaya, Juan-Manuel
AU - Cunninghame-Graham, Deborah S
AU - Huang, Andrew J W
AU - Brennan, Michael T
AU - Hughes, Pamela
AU - Alevizos, Ilias
AU - Miceli-Richard, Corinne
AU - Keystone, Edward C
AU - Bykerk, Vivian P
AU - Hirschfield, Gideon
AU - Xie, Gang
AU - Nordmark, Gunnel
AU - Bucher, Sara Magnusson
AU - Eriksson, Per
AU - Omdal, Roald
AU - Rhodus, Nelson L
AU - Rischmueller, Maureen
AU - Rohrer, Michael
AU - Wahren-Herlenius, Marie
AU - Witte, Torsten
AU - Alarcon-Riquelme, Marta
AU - Mariette, Xavier
AU - Lessard, Christopher J
AU - Harley, John B
AU - Ng, Wan-Fai
AU - Rasmussen, Astrid
AU - Sivils, Kathy L
AU - Scofield, R Hal
N1 - © 2017, American College of Rheumatology.
PY - 2017/7/10
Y1 - 2017/7/10
N2 - BACKGROUND: Sjögren's syndrome and systemic lupus erythematosus (SLE) are related by clinical and serological manifestations as well as genetic risks. Both diseases are more commonly found in women compared to men at a ratio of about 10 to 1. Common X chromosome aneuploidies, 47,XXY and 47,XXX, are enriched among men and women, respectively, in either disease suggesting a dose effect on the X chromosome.METHODS: We examined cohorts of Sjögren's syndrome or SLE patients with intensity plots of X chromosome single nucleotide polymorphism (SNP) alleles along with karyotype of selected subjects.RESULTS: Among ∼2500 women with SLE we found three patients with a triple mosaic consisting of 45,X/46,XX/47,XXX. Among ∼2100 women with Sjögren's syndrome, one patient had 45,X/46,XX/47,XXX with a triplication of the distal p arm of the X chromosome in the 47,XXX cells. Neither the triple mosaic nor the partial triplication were found among controls. In another Sjögren's cohort, we found a mother-daughter pair with partial triplication of this same region of the X chromosome. The triple mosaic occurs in approximately 1 in 25,000 to 50,000 live female births, while partial triplications such are even rarer.CONCLUSIONS: Very rare X chromosome abnormalities are present among patients with either Sjögren's or SLE, and may inform the location of a gene(s) that mediate an X dose effect as well as critical cell types in which such effect is operative. This article is protected by copyright. All rights reserved.
AB - BACKGROUND: Sjögren's syndrome and systemic lupus erythematosus (SLE) are related by clinical and serological manifestations as well as genetic risks. Both diseases are more commonly found in women compared to men at a ratio of about 10 to 1. Common X chromosome aneuploidies, 47,XXY and 47,XXX, are enriched among men and women, respectively, in either disease suggesting a dose effect on the X chromosome.METHODS: We examined cohorts of Sjögren's syndrome or SLE patients with intensity plots of X chromosome single nucleotide polymorphism (SNP) alleles along with karyotype of selected subjects.RESULTS: Among ∼2500 women with SLE we found three patients with a triple mosaic consisting of 45,X/46,XX/47,XXX. Among ∼2100 women with Sjögren's syndrome, one patient had 45,X/46,XX/47,XXX with a triplication of the distal p arm of the X chromosome in the 47,XXX cells. Neither the triple mosaic nor the partial triplication were found among controls. In another Sjögren's cohort, we found a mother-daughter pair with partial triplication of this same region of the X chromosome. The triple mosaic occurs in approximately 1 in 25,000 to 50,000 live female births, while partial triplications such are even rarer.CONCLUSIONS: Very rare X chromosome abnormalities are present among patients with either Sjögren's or SLE, and may inform the location of a gene(s) that mediate an X dose effect as well as critical cell types in which such effect is operative. This article is protected by copyright. All rights reserved.
U2 - 10.1002/art.40207
DO - 10.1002/art.40207
M3 - Article
C2 - 28692793
SN - 2326-5191
JO - Arthritis & Rheumatology (Hoboken)
JF - Arthritis & Rheumatology (Hoboken)
ER -